Orally disintegrating carbidopa/levodopa

By Slevin John T   Ryan Melody  

Future Neurology, Vol. 1, Iss. 2, 2006-03 ,pp. : 139-147

Future Medicine

Access to resources Recommend Favorite

Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers

By Dutta S.   Zhang Y.   Selness D.S.   Lee L.L.   Williams L.A.   Sommerville K.W.  

Epilepsy Research, Vol. 49, Iss. 1, 2002-03 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite

Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson’s patients

By Stocchi F.   Barbato L.   Nordera G.   Bolner A.   Caraceni T.  

Journal of Neural Transmission, Vol. 111, Iss. 2, 2004-02 ,pp. : 173-180

Springer Publishing Company

Access to resources Recommend Favorite

Carbamazepine Extended-Release Capsules in the Treatment of Bipolar Disorder

By Ginsberg Lawrence  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 1, 2006-03 ,pp. : 1-1

Informa Healthcare

Access to resources Recommend Favorite

Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease

By Cáceres-Redondo María   Carrillo Fátima   Lama María   Huertas-Fernández Ismael   Vargas-González Laura   Carballo Manuel   Mir Pablo  

Journal of Neurology, Vol. 261, Iss. 3, 2014-03 ,pp. : 561-569

Springer Publishing Company

Access to resources Recommend Favorite